Related Experiment Videos
Membrane components can modulate the substrate specificity of protein kinase C
1Department of Biochemistry, McMaster University, Hamilton, Ontario, Canada.
Molecular and Cellular Biochemistry
|January 26, 1995
Summary
A novel cationic amphiphile alters protein kinase C (PKC) substrate specificity. It inhibits histone phosphorylation but activates protamine sulfate phosphorylation, suggesting new signaling pathway modulation mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Signaling
Background:
- Protein kinase C (PKC) plays a crucial role in cellular signaling pathways.
- PKC activity and substrate specificity are regulated by interactions with lipids and cofactors.
- Understanding these regulatory mechanisms is key to deciphering complex cellular processes.
Purpose of the Study:
- To investigate the effect of a specific cationic amphiphile, cholesteryl-3 beta-carboxyamidoethylene-trimethylammonium iodide, on the substrate specificity of protein kinase C (PKC).
- To elucidate the mechanisms by which this amphiphile modulates PKC activity towards different substrates.
- To explore the potential for altering PKC-dependent signal transduction pathways.
Main Methods:
- Utilized large unilamellar vesicles (LUVs) composed of specific lipids (POPS, POPC) and the cationic amphiphile.
- Assessed the binding of PKC to these LUVs.
- Measured the rate of histone and protamine sulfate phosphorylation catalyzed by PKC under various conditions.
- Investigated the role of phosphatidylserine (PS) and Ca2+ in modulating PKC activity.
Main Results:
- The cationic amphiphile reduced PKC binding to lipids and inhibited histone phosphorylation.
- Conversely, PKC bound to LUVs containing the amphiphile exhibited a four-fold increase in protamine sulfate phosphorylation rate.
- This activation was dependent on phosphatidylserine (PS) and inhibited by Ca2+, with incubation time also affecting the extent of activation.
Conclusions:
- The cationic amphiphile, cholesteryl-3 beta-carboxyamidoethylene-trimethylammonium iodide, can switch the substrate specificity of protein kinase C (PKC).
- This modulation offers a novel mechanism for altering PKC-dependent signal transduction by changing the enzyme's protein targets.
- Further research into such modulators could reveal new therapeutic strategies for diseases involving aberrant PKC signaling.